LANXESS suspends share buy-backs on coronavirus impacts

Stefan Baumgarten

07-Apr-2020

LONDON (ICIS)–LANXESS has decided to suspend its recently initiated share buy-back programme for an indefinite period because of the coronavirus (Covid-19) pandemic.

The programme has a total volume of up to €500m and was initiated on 12 March with a first tranche of up to €250m.

In view of the challenges from the pandemic, LANXESS needed to conserve its liquidity, CFO chief financial officer Michael Pontzen said in a statement late on Monday.

Only two weeks ago, LANXESS said that it intended to continue with the share buy-back programme.

A number of other firms – including Shell, Total and Stolt-Nielsen – recently suspended buy-backs to preserve liquidity in the face of the crisis.

Visit the ICIS coronavirus topic page for analysis of the impact on chemical markets and links to latest news.

Additional reporting by Tom Brown

READ MORE

Global News + ICIS Chemical Business (ICB)

See the full picture, with unlimited access to ICIS chemicals news across all markets and regions, plus ICB, the industry-leading magazine for the chemicals industry.

Contact us

Partnering with ICIS unlocks a vision of a future you can trust and achieve. We leverage our unrivalled network of industry experts to deliver a comprehensive market view based on independent and reliable data, insight and analytics.

Contact us to learn how we can support you as you transact today and plan for tomorrow.

READ MORE